; or (cc) 100 if the practitioner provides medication-assisted treatment (MAT) using covered medications (as defined in section 8.2 of title 42, Code of Federal Regulations (or successor regulations)) in a qualified practice setting (as described in section 8.615 of title 42, Code of Federal Regulations (or successor regulations)). . (b) Extending the time limitation for nurse practitioners and physician assistants To become qualifying practitioners Section 303(g)(2)(G)(iii)(II) of the Controlled Substances Act ( 21 U.S.C. 823(g)(2)(G)(iii)(II) ) is amended by striking 2021 and inserting 2028 . 3. Confidentiality and disclosure of records relating to substance use disorder (a) Conforming changes relating to substance use disorder Subsections (a) and (h) of section 543 of the Public Health Service Act ( 42 U.S.C. 290dd–2 ) are each amended by striking substance abuse and inserting substance use disorder . (b) Disclosures to covered entities consistent with HIPAA Paragraph (2) of section 543(b) of the Public Health Service Act ( 42 U.S.C. 290dd–2(b) ) is amended by adding at the end the following: (D) To a covered entity or to a program or activity described in subsection (a), for the purposes of treatment, payment, and health care operations, so long as such disclosure is made in accordance with HIPAA privacy regulation. Any redisclosure of information so disclosed may only be made in accordance with this section. . (c) Disclosures of de-Identified health information to public health authorities Paragraph (2) of section 543(b) of the Public Health Service Act ( 42 U.S.C. 290dd–2(b) ), as amended by subsection (b), is further amended by adding at the end the following: (E) To a public health authority, so long as such content does not include any individually identifiable health information and meets the standards established in section 164.514 of title 45, Code of Federal Regulations (or successor regulations) for creating de-identified information. . (d) Definitions Subsection (b) of section 543 of the Public